Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Histopathological and Immunohistochemical Studies of Cowpox Virus Replication in a Three-Dimensional Skin Model.

Tamošiūnaitė A, Hoffmann D, Franke A, Schluckebier J, Tauscher K, Tischer BK, Beer M, Klopfleisch R, Osterrieder N.

J Comp Pathol. 2016 Jul;155(1):55-61. doi: 10.1016/j.jcpa.2016.05.001. Epub 2016 Jun 9.

PMID:
27291992
2.

Prevalence of equine gammaherpesviruses on breeding farms in Turkey and development of a TaqMan MGB real-time PCR to detect equine herpesvirus 5 (EHV-5).

Akkutay AZ, Osterrieder N, Damiani A, Tischer BK, Borchers K, Alkan F.

Arch Virol. 2014 Nov;159(11):2989-95. doi: 10.1007/s00705-014-2165-5. Epub 2014 Jul 10.

PMID:
25008897
3.

Identification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes.

Xu Z, Zikos D, Tamošiūnaitė A, Klopfleisch R, Osterrieder N, Tischer BK.

J Virol. 2014 Aug;88(15):8615-28. doi: 10.1128/JVI.00901-14. Epub 2014 May 21.

4.

Generation of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genes.

Xu Z, Zikos D, Osterrieder N, Tischer BK.

J Virol. 2014 Jan;88(1):490-502. doi: 10.1128/JVI.02385-13. Epub 2013 Oct 23.

5.

Phocine herpesvirus 1 (PhHV-1) in harbor seals from Svalbard, Norway.

Roth SJ, Tischer BK, Kovacs KM, Lydersen C, Osterrieder N, Tryland M.

Vet Microbiol. 2013 Jun 28;164(3-4):286-92. doi: 10.1016/j.vetmic.2013.03.008. Epub 2013 Mar 21.

PMID:
23570865
6.

Generation and characterization of a Cowpox virus mutant lacking host range factor CP77.

Schuenadel L, Tischer BK, Nitsche A.

Virus Res. 2012 Sep;168(1-2):23-32. doi: 10.1016/j.virusres.2012.06.005. Epub 2012 Jun 13.

PMID:
22705200
7.

Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences.

Tischer BK, Kaufer BB.

J Biomed Biotechnol. 2012;2012:472537. doi: 10.1155/2012/472537. Epub 2012 Feb 23. Review.

8.

Cowpox virus serpin CrmA is necessary but not sufficient for the red pock phenotype on chicken chorioallantoic membranes.

Roth SJ, Klopfleisch R, Osterrieder N, Tischer BK.

Virus Res. 2012 Jan;163(1):254-61. doi: 10.1016/j.virusres.2011.10.002. Epub 2011 Oct 12.

PMID:
22016035
9.

Cloning the simian varicella virus genome in E. coli as an infectious bacterial artificial chromosome.

Gray WL, Zhou F, Noffke J, Tischer BK.

Arch Virol. 2011 May;156(5):739-46. doi: 10.1007/s00705-010-0889-4. Epub 2011 Apr 13.

10.

Simian varicella virus open reading frame 63/70 expression is required for efficient virus replication in culture.

Brazeau E, Wellish M, Kaufer BB, Tischer BK, Gray W, Zhou F, Osterrieder N, Hanlon T, Golive A, Hall T, Nair S, Owens GP, Mueller NH, Cohrs RJ, Pugazhenthi S, Gilden D, Mahalingam R.

J Neurovirol. 2011 Jun;17(3):274-80. doi: 10.1007/s13365-011-0025-6. Epub 2011 Apr 9.

11.

Recovery of infectious virus from full-length cowpox virus (CPXV) DNA cloned as a bacterial artificial chromosome (BAC).

Roth SJ, Höper D, Beer M, Feineis S, Tischer BK, Osterrieder N.

Vet Res. 2011 Jan 11;42:3. doi: 10.1186/1297-9716-42-3.

12.

En passant mutagenesis: a two step markerless red recombination system.

Tischer BK, Smith GA, Osterrieder N.

Methods Mol Biol. 2010;634:421-30. doi: 10.1007/978-1-60761-652-8_30.

PMID:
20677001
13.

Red-mediated transposition and final release of the mini-F vector of a cloned infectious herpesvirus genome.

Wussow F, Fickenscher H, Tischer BK.

PLoS One. 2009 Dec 4;4(12):e8178. doi: 10.1371/journal.pone.0008178.

14.

Herpesviruses--a zoonotic threat?

Tischer BK, Osterrieder N.

Vet Microbiol. 2010 Jan 27;140(3-4):266-70. doi: 10.1016/j.vetmic.2009.06.020. Epub 2009 Jun 21. Review.

15.

First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.

Schmidt M, Korn K, Nübling CM, Chudy M, Kress J, Horst HA, Geusendam G, Hennig H, Sireis W, Rabenau HF, Doerr HW, Berger A, Hourfar MK, Gubbe K, Karl A, Fickenscher H, Tischer BK, Babiel R, Seifried E, Gürtler L.

Transfusion. 2009 Sep;49(9):1836-44. doi: 10.1111/j.1537-2995.2009.02203.x. Epub 2009 May 11.

PMID:
19453990
16.

A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.

Tischer BK, Kaufer BB, Sommer M, Wussow F, Arvin AM, Osterrieder N.

J Virol. 2007 Dec;81(23):13200-8. Epub 2007 Oct 3.

17.

Cryopreservation of cellular products in a closed-bag system with an incorporated dimethyl sulfoxide-resistant sterile filter outside of cleanroom facilities.

Humpe A, Jansen P, Tischer BK, Schubert S, Beck C, Adamzik ID, Maas JH, Strate A, Gramatzki M, Riggert J.

Transfusion. 2007 Jun;47(6):1033-41.

PMID:
17524094
18.

Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins.

Rosas CT, König P, Beer M, Dubovi EJ, Tischer BK, Osterrieder N.

J Gen Virol. 2007 Mar;88(Pt 3):748-57.

PMID:
17325347
19.

Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).

Rosas CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N.

Virus Res. 2007 Apr;125(1):69-78. Epub 2007 Jan 22.

PMID:
17241683
20.

Marek's disease virus: lytic replication, oncogenesis and control.

Jarosinski KW, Tischer BK, Trapp S, Osterrieder N.

Expert Rev Vaccines. 2006 Dec;5(6):761-72. Review.

PMID:
17184215
21.

A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis.

Trapp S, Parcells MS, Kamil JP, Schumacher D, Tischer BK, Kumar PM, Nair VK, Osterrieder N.

J Exp Med. 2006 May 15;203(5):1307-17. Epub 2006 May 1.

22.

Marek's disease virus: from miasma to model.

Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S.

Nat Rev Microbiol. 2006 Apr;4(4):283-94. Review.

PMID:
16541136
23.

Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli.

Tischer BK, von Einem J, Kaufer B, Osterrieder N.

Biotechniques. 2006 Feb;40(2):191-7.

24.

vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus.

Kamil JP, Tischer BK, Trapp S, Nair VK, Osterrieder N, Kung HJ.

J Virol. 2005 Jun;79(11):6984-96.

25.

High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro.

Tischer BK, Schumacher D, Chabanne-Vautherot D, Zelnik V, Vautherot JF, Osterrieder N.

J Virol. 2005 May;79(10):5889-99.

27.

A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens.

Tischer BK, Schumacher D, Beer M, Beyer J, Teifke JP, Osterrieder K, Wink K, Zelnik V, Fehler F, Osterrieder N.

J Gen Virol. 2002 Oct;83(Pt 10):2367-76.

PMID:
12237417
28.

Generation of a permanent cell line that supports efficient growth of Marek's disease virus (MDV) by constitutive expression of MDV glycoprotein E.

Schumacher D, Tischer BK, Teifke JP, Wink K, Osterrieder N.

J Gen Virol. 2002 Aug;83(Pt 8):1987-92.

PMID:
12124462
29.

The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells.

Tischer BK, Schumacher D, Messerle M, Wagner M, Osterrieder N.

J Gen Virol. 2002 May;83(Pt 5):997-1003.

PMID:
11961253
31.

Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells.

Schumacher D, Tischer BK, Reddy SM, Osterrieder N.

J Virol. 2001 Dec;75(23):11307-18.

Supplemental Content

Loading ...
Support Center